⌛ Did you miss ProPicks’ 13% gains in May? Subscribe now & catch June’s top AI-picked stocks early.Unlock Stocks

BRIEF-ICC Labs Enters Into LoI With Eurofarma Uruguay

Published 2018-04-19, 07:40 a/m
© Reuters.  BRIEF-ICC Labs Enters Into LoI With Eurofarma Uruguay
ICC
-

April 19 (Reuters) - ICC Labs Inc ICC.V :

* ICC LABS ENTERS INTO LETTER OF INTENT WITH EUROFARMA URUGUAY S.A., A MEMBER OF THE BRAZILIAN-OWNED MULTINATIONAL EUROFARMA GROUP OF PHARMACEUTICAL COMPANIES

* ICC LABS INC SAYS ONE OF ITS URUGUAYAN SUBSIDIARIES HAS ENTERED INTO A LETTER OF INTENT WITH EUROFARMA URUGUAY S.A

* ICC LABS-TO NEGOTIATE AGREEMENTS PURSUANT TO WHICH EUROFARMA TO BLEND, BOTTLE, PACKAGE, FOR SALE BY CO, VARIOUS PRODUCTS DERIVED FROM CBD EXTRACTIONS

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.